BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed XBIT catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:83d004e0bcbdc34b66ad@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270116
SUMMARY:XBIT P2 readout (est.): Natrunix in Combination With Methotrexate f
 or Rheumatoid Arthritis Treatment
DESCRIPTION:Natrunix in Combination With Methotrexate for Rheumatoid Arthri
 tis Treatment\nNCT06590090 | PHASE2 | NOT_YET_RECRUITING | sponsor: XBiote
 ch\, Inc.\nPrimary completion date (ESTIMATED)\; top-line results usually 
 follow later.\nTicker XBIT (confidence 0.9)\nSource: https://clinicaltrial
 s.gov/study/NCT06590090\nScheduling/reference data from public records\; d
 ates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06590090
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
